[ad_1] In Japan, Zai announced to have confirmed a significant inhibition of the progression of the Phase II clinical trial (201 test) of the early treatment antibody of Alzheimer's disease "BAN2401 Which …
Read More »[약업신문] Ezai, initial dementia about 2 inhibition of confirmation of progression
